Position in VERA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$12,628,438
-$31,411,954 QoQ
Shares Held
313,906
-63.9% QoQ
Ownership
0.436%
of shares outstanding
% of Portfolio
1.20%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VERA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026First Light Asset Management, LLC holds $573,690,960 across 11 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | APGE |
Apogee Therapeutics, Inc.
|
930,289 | $123,477,258 | |
| 2 | PVLA |
Palvella Therapeutics, Inc.
|
771,901 | $117,961,910 | |
| 3 | ELVN |
Enliven Therapeutics, Inc.
|
1,360,750 | $69,058,062 | |
| 4 | CRNX |
Crinetics Pharmaceuticals, Inc.
|
1,360,866 | $50,923,605 | |
| 5 | EWTX |
Edgewise Therapeutics, Inc.
|
1,095,171 | $44,496,797 | |
| 6 | ANAB |
Anaptysbio, Inc
|
582,004 | $39,285,270 | |
| 7 | TRVI |
Trevi Therapeutics, Inc.
|
2,097,215 | $39,113,059 | |
| 8 | SEPN |
Septerna, Inc.
|
963,260 | $32,259,577 |
All Filings in VERA
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $12,628,438 | 313,906 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $44,040,392 | 869,676 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $14,736,238 | 507,097 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $13,263,832 | 562,981 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $28,244,613 | 1,175,879 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $53,338,093 | 1,261,246 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $31,171,342 | 705,234 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $36,387,058 | 1,005,723 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $18,806,054 | 436,133 | Shares | Sole | 2024-05-15 | |
| No filing history on record for this holder in this stock. | ||||||